AG142005: β-D-GalNAc-Butyl-Carboxylic Acid Pack Size:100 mg Fmoc-L-Ser(GlcNAcβ(1-3)GalNAc)-OH (Peracetate)

Fmoc-L-Ser(GlcNAcβ(1-3)GalNAc)-OH (Peracetate)

C97H151N23O35S / 2233

and in high-throughput screening formats

with the sugar hydroxyl groups protected as acetate esters

AG142005: β-D-GalNAc-Butyl-Carboxylic Acid Pack Size:100 mg Fmoc-L-Ser(GlcNAcβ(1-3)GalNAc)-OH (Peracetate)C13H23NO8 321. 32 A D N acetylgalactosamine (GalNAc) ligand equipped with a terminal carboxylic acid through a short butyl spacer. The carboxylic acid can be activated to NHS, sulfo NHS, or pentafluorophenyl (PFP) esters and reacted with amine functionalized platforms or lysine residues on proteins and peptides to form stable amide bonds. This compound enables the construction of hepatocyte targeted therapeutics and research tools that exploit the